Keyphrases
Autoantibodies
100%
Melanoma Patients
100%
Recurrence-free Interval
100%
Adjuvant Interferon
100%
Autoimmune Recurrence
100%
Antibody-free
100%
Interferon-α (IFN-α)
70%
Confidence Interval
60%
Hazard Ratio
60%
Cancer Treatment
50%
European Organizations
50%
Randomized Trial
20%
Melanoma Treatment
20%
Time Bias
20%
Guarantee Time
20%
Relapse-free Interval
20%
Statistical Test
10%
Enzyme-linked Immunosorbent Assay (ELISA)
10%
Autoimmunity
10%
Recurrence Risk
10%
Cox Model
10%
Positive Check
10%
Treatment Initiation
10%
Intermediate Dose
10%
Improved Prognosis
10%
Clinical Manifestations
10%
Variable Model
10%
Anti-thyroglobulin Antibody
10%
Anticardiolipin Antibodies
10%
Random Assignment
10%
Autoantibody Detection
10%
Antinuclear Antibodies
10%
Mathematics
Confidence Interval
100%
Treated Patient
100%
Free Interval
100%
Hazard Ratio
100%
Randomized Trial
33%
Proportional Hazards Model
16%
Random Assignment
16%
Statistical Test
16%
Immunology and Microbiology
interferon
100%
Autoantibodies
100%
Enzyme-Linked Immunosorbent Assay
9%
Autoimmunity
9%
Cardiolipin Antibody
9%
Thyroglobulin Antibody
9%
Antinuclear Antibody
9%